Delivery Order SPE2DR25D2009-SPE2DR26FJ3H1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,026.98 to AmerisourceBergen Drug Corp for the supply of Clotrimazole 1% Topical Cream in 15-gram units. This firm fixed-price contract was competitively awarded without set-aside restrictions and carries an ultimate completion date of July 30, 2025. The award was issued on July 29, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clotrimazole 1% topical cream in 30-gram units, with a contract ceiling value of $1,933.00 and a completion date of July 31, 2025. This competitively awarded, non-set-aside firm fixed price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a small-value transaction within...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1% Clotrimazole topical cream, a medication used to treat fungal infections. The contract has a firm fixed price of $1,948.06 and a period of performance through April 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
- The Defense Logistics Agency awarded a $95,950 delivery order to Amerisourcebergen Drug Corporation for clotrimazole 1% topical cream. The firm fixed price order is under the DLA's pharmaceutical prime vendor contract and calls for the delivery of 15 grams of the antifungal cream to a facility in Conshohocken, Pennsylvania. Performance will take place between June 23 and June 26 of this year. Amerisourcebergen will fulfill the order as the prime vendor for pharmaceutical products supporting...
- The Defense Logistics Agency awarded a $35,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for clotrimazole 1% vaginal cream. Under this contract, Amerisourcebergen will deliver 45 grams of the vaginal cream to a location in Conshohocken, Pennsylvania by August 24, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the U.S....
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $14,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to provide 4561362830 clotrimazole 1% solution 10mL. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 28, 2023 through June 29, 2023. No additional details were provided regarding the original solicitation or...
- The Defense Logistics Agency Troop Support Medical awarded a $224.16 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4561664708 Clotrimazole 1% topical cream in 30gm quantities. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order runs from August 1st through August 2nd, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will perform as the prime contractor without involvement of...
- The Defense Logistics Agency awarded a $66,160 delivery order to Amerisourcebergen Drug Corporation for clotrimazole 1% solution. Under the firm fixed price contract, Amerisourcebergen will provide 30ml bottles of the antifungal solution to locations in Conshohocken, Pennsylvania by August 14, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring medical supplies and pharmaceuticals to support military treatment facilities...
- The Defense Logistics Agency awarded a $9,950 firm fixed price delivery order to Amerisourcebergen Drug Corporation for clotrimazole-betamethasone cream. As the prime contractor, Amerisourcebergen will deliver 15 grams of the prescribed topical medication to an agency location in Conshohocken, Pennsylvania by July 14, 2023. The single award was made against Amerisourcebergen's Corporate Office Division contract vehicle with the DLA to supply pharmaceutical products in support of Department of...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for Lamisil 1% cream in a 30-gram unit, with a ceiling value of $1,621.52. This is a firm fixed-price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for ultimate completion by October 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ3H1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,849.40 to AmerisourceBergen Drug Corp for the supply of Clotrimazole 1% Topical Cream in 30-gram quantities. This firm fixed price delivery order, issued on November 18, 2025, with an ultimate completion date of November 19, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for the federal government's medical supply chain, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and medical devices across multiple therapeutic domains. The structure reflects the DLA's strategy to maintain flexible, comprehensive pharmaceutical support across federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 11/18/25 |